Meeting News
October 12, 2019
American Society for Radiation Oncology chose Corey J. Langer, MD, as its 2019 honorary member. The award is the highest honor that ASTRO bestows…
In the Journals
September 23, 2019
Ultra-hypofractionated stereotactic body radiotherapy did not appear to increase acute toxicity compared with conventionally fractionated therapy…
Meeting News
September 22, 2019
The American Society for Radiation Oncology honored three of its members with the Gold Medal Award. This year’s recipients were Walter J…
Meeting NewsPerspective
September 19, 2019
Durvalumab extended the time to first progression and reduced the risk for local and distant progression among patients with unresectable stage III…
Meeting NewsPerspective
September 18, 2019
Stereotactic ablative radiation appeared to be an effective and safe treatment for men with oligometastatic prostate cancer, with significant…
Meeting NewsPerspective
September 17, 2019
Patients who received radiation therapy before chimeric antigen receptor T-cell therapy for relapsed or refractory non-Hodgkin lymphoma were less…
Meeting NewsPerspective
September 17, 2019
The addition of stereotactic body radiotherapy after progression on pembrolizumab prolonged PFS among patients with metastatic non-small cell lung…
Meeting NewsPerspective
September 16, 2019
Long-term antiandrogen therapy did not improve OS when administered during early salvage radiation therapy among patients with recurrent prostate…
Meeting NewsPerspective
December 5, 2018
Whole-breast radiation significantly decreased local recurrence and invasive local recurrence among a subset of women with favorable-riskductal…
Meeting NewsPerspective
December 5, 2018
Women with early breast cancer who received once-weekly, hypofractionated radiotherapy exhibited low rates of normal tissue effects comparable to…